Cargando…
Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
BACKGROUND: Pseudomonas aeruginosa infection is the major cause of death in burn patients. Thus, in this study, a chimeric vaccine harboring the OprF(185–350)–OprI(22–83)–PcrV was designed and expressed in Escherichia coli. The immunogenicity of the recombinant chimer, OprI, OprF, and PcrV was studi...
Autores principales: | Fakoor, Mohammad Hadi, Mousavi Gargari, Seyed Latif, Owlia, Parviz, Sabokbar, Azar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294051/ https://www.ncbi.nlm.nih.gov/pubmed/32606816 http://dx.doi.org/10.2147/IDR.S244081 |
Ejemplares similares
-
Immunopotentiating properties of chimeric OprF-OprI-PopB protein against Pseudomonas aeruginosa PAO1 in the infected burned rat model
por: Sabzehali, Fattaneh, et al.
Publicado: (2022) -
Conserved OprF as a Selective Immunogen against Pseudomonas aeruginosa
por: Kazemi Moghaddam, Ehsan, et al.
Publicado: (2017) -
Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023) -
Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017) -
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
por: Wang, Xingyun, et al.
Publicado: (2023)